APTV vs TERN · P/E 41, rev $19.71B vs $6.12B cap
Aptiv PLC (APTV) versus Terns Pharmaceuticals Inc (TERN) — a side-by-side from cached financials, not a winner call.
Aptiv PLC (APTV) is a auto parts company listed on US.
Terns Pharmaceuticals Inc (TERN) is a biotechnology company listed on NASDAQ.
Latest reported APTV revenue for 2024-12-31 was $19.71B. Net income was $275.0M. Revenue was down 1.7% from 2023-12-31 to 2024-12-31. APTV currently screens at market cap $14.52B and trailing P/E 40.8.
Latest reported TERN revenue for 2022-12-31 was $0. Net income was -$60.3M. TERN currently screens at market cap $6.12B.
APTV currently screens at market cap $14.52B and trailing P/E 40.8. TERN currently screens at market cap $6.12B.
Not investment advice. Open the APTV and TERN stock pages for the full models.
Not investment advice.